STAT - Reporting from the frontiers of health and medicine

Don't Miss

Politics

Pharma

First Opinion The EPA’s proposed ‘transparency rule’ will harm health, safety, and the environment
Biotech Constellation’s blood cancer drug shows strong results, but skepticism may not fade
Biotech Vindicated. New J&J CAR-T myeloma data confirm strong efficacy, ease doubts raised by Chinese version
Health Pete Frates, who raised millions for ALS research by championing the Ice Bucket Challenge, dies at 34
First Opinion H.R. 3 is the wrong path to lower drug costs

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’
Lawmakers ask HHS for greater oversight of patient assistance programs
More hospital drug spending is going toward cancer immunotherapies

Health

Health

Health

Health

Don't Miss

By STAT

Special Report

Pharma Sanofi says Dupixent could be a $10 billion drug, aims to sell Cialis and Tamiflu over the counter
Biotech Merck and Sanofi buy smaller cancer drug firms at big premiums, fueling investor excitement
Politics House Republicans fuel Capitol Hill chaos with competing drug pricing bill
Biotech Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’
Don't Miss ‘You keep loving each other’: A window into dementia at the end of a lifelong partnership